Biosimilars Forum ( Biosimilars Forum)

Primary tabs

Biosimilars Forum's picture

Management

Contact Address

About Biosimilars Forum

The Biosimilars Forum is a nonprofit organization whose mission is to advance biosimilars in the United States with the intent of expanding access and availability of biological medicines, and improving health care. The founding members of the Biosimilars Forum represent the majority of companies with the most significant U.S. biosimilars development portfolios.

Biosimilars Forum press release, blog etc

Mon, 10/03/2022 - 21:12 Biosimilars Forum Applauds CMS Biosimilars Measure
Thu, 07/21/2022 - 13:45 The Biosimilars Forum Launches Updated Website Content
Thu, 03/31/2022 - 03:42 HHS Inspector General Report: Biosimilars Could Generate Significant Medicare Part D Savings
Wed, 03/09/2022 - 15:10 Biosimilars Forum Executive Director to Discuss Current Biosimilars Landscape at World Biosimilars Congress
Tue, 03/01/2022 - 12:17 Biosimilars Forum Welcomes HHS Inspector General Study on Biosimilars in Medicare Part B
Tue, 02/22/2022 - 04:17 Report Highlights Employer Savings from Increased Employee Access to Biosimilars
Wed, 02/02/2022 - 22:56 Biosimilars Forum Supports the Negotiated BsUFA III Agreement in Capitol Hill Testimony
Sun, 01/30/2022 - 21:29 Juliana M. Reed Named Executive Director of the Biosimilars Forum
Mon, 10/25/2021 - 23:18 Biosimilars Forum to Congress: Incentivize Biosimilars in Build Back Better Act
Wed, 10/20/2021 - 12:48 Biosimilars Forum Applauds FDAs Approval of Second Interchangeable Biosimilar
Wed, 10/13/2021 - 10:35 New Report Finds Biosimilars Could Save States Billions of Dollars Annually
Mon, 09/20/2021 - 17:31 First Biosimilar to Treat Eye Disease Gains FDA Approval
Thu, 09/09/2021 - 14:51 Biden Administrations Plan to Lower Prescription Drug Prices Supports Biosimilar Competition, which will Decrease Drug Costs
Thu, 07/15/2021 - 08:02 Food & Drug Administration Takes Strong Enforcement Action Against Biosimilar Misinformation
Fri, 07/09/2021 - 12:41 President Bidens Executive Order to Support Biosimilar Drugs Will Provide Lower Cost Options for Patients
Thu, 06/17/2021 - 13:49 The Biosimilars Forum Applauds SCOTUS Decision to Uphold ACA and US Pathway for Biosimilar Approval
Mon, 06/14/2021 - 13:11 New Report Shows Biosimilars Significantly Lowered Prices of All Biologics
Thu, 06/10/2021 - 01:51 Lowering Prices with Biosimilars: ASP+8: Stakeholder Meeting Round-Up